CLIA Rubella IgG
Chemiluminescence kit for the detection of IgG antibodies to Rubella in human serum or plasma
Chemiluminescence kit for the detection of IgG antibodies to Rubella in human serum or plasma
Catalog Number: | CL-RubG100 |
---|---|
Size: | 100 tests |
Regulatory status: | CE IVD |
Clinical topic: | Infectious Diseases |
Diagnostic panel: |
Childhood Diseases TORCH |
Rubella is an exanthem viral disease of children and adolescents where it is a benign disease terminating without any lasting effects. The virus is transmitted by droplet infection or via the placenta.
Rubella can be a very serious maternal infection; the virus entering through the placenta often causes miscarriages or birth defects. The risk of embryo defects decreases with the length of pregnancy the highest risk is during the first trimester. Rubella is one of the infections of TORCH syndrome.
Reinfections occur more frequently in vaccinated individuals than in naturally immune ones. Most of these reinfections pass without any symptoms. Rubella reinfections in pregnancy seldomly lead to the infection of the fetus.
Both IgM and IgG antibodies are induced by acute infection. Class IgG antibodies remain for a long time, usually for the whole life. A significant increase of IgG antibody levels occurs also after vaccination even though the titers of these antibodies are generally lower than after undergoing natural infection.
Assay time | 30 min |
Assay stability | 30 days on board stability / In use stability until the expiration date at storage temperature 2-8 °C |
Sample matrix | Serum, Plasma |
Sample volume | 10 µL |
Measuring range | 0,1 - 200 IU/ml |
Assay/kit content | Reagent Cartridge with specific reagents for the assay, magnetic particles, calibrators |
Complementary products | Wash buffer, AnchorĀ® Tips, Stackable cuvettes, Trigger solutions |
Note | The kits are CE-IVD certified and intended for professional use. |